{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T03:19:20Z","timestamp":1785467960886,"version":"3.56.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"DOI":"10.7759\/cureus.35663","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T02:06:42Z","timestamp":1677722802000},"source":"Crossref","is-referenced-by-count":2,"title":["Progressive Systemic Sclerosis With Negative Antinuclear Antibodies and Absence of Raynaud\u2019s Phenomenon: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Anna C","family":"Falls","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Wrigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surabhi A","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu530","article-title":"Performance of the new ACR\/EULAR classification criteria for systemic sclerosis in clinical practice","volume":"54","author":"Jordan S","year":"2015","unstructured":"Jordan S, Maurer B, Toniolo M, Michel B, Distler O. Performance of the new ACR\/EULAR classification criteria for systemic sclerosis in clinical practice. Rheumatology (Oxford). 2015, 54:1454-8. 10.1093\/rheumatology\/keu530","journal-title":"Rheumatology (Oxford)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/ar628","article-title":"The clinical relevance of autoantibodies in scleroderma","volume":"5","author":"Ho KT","year":"2003","unstructured":"Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther. 2003, 5:80-93. 10.1186\/ar628","journal-title":"Arthritis Res Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8718-8","article-title":"Antinuclear antibodies in systemic sclerosis: an update","volume":"58","author":"Stochmal A","year":"2020","unstructured":"Stochmal A, Czuwara J, Trojanowska M, Rudnicka L. Antinuclear antibodies in systemic sclerosis: an update. Clin Rev Allergy Immunol. 2020, 58:40-51. 10.1007\/s12016-018-8718-8","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00167","article-title":"Autoantibodies in systemic sclerosis: unanswered questions","volume":"6","author":"Kayser C","year":"2015","unstructured":"Kayser C, Fritzler MJ. Autoantibodies in systemic sclerosis: unanswered questions. Front Immunol. 2015, 6:167. 10.3389\/fimmu.2015.00167","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes315","article-title":"Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"52","author":"Schneeberger D","year":"2013","unstructured":"Schneeberger D, Tyndall A, Kay J, et al.. Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database. Rheumatology (Oxford). 2013, 52:560-7. 10.1093\/rheumatology\/kes315","journal-title":"Rheumatology (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.11.006","article-title":"Antinuclear antibody-negative systemic sclerosis","volume":"44","author":"Salazar GA","year":"2015","unstructured":"Salazar GA, Assassi S, Wigley F, et al.. Antinuclear antibody-negative systemic sclerosis. Semin Arthritis Rheum. 2015, 44:680-6. 10.1016\/j.semarthrit.2014.11.006","journal-title":"Semin Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.127621","article-title":"Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma","volume":"70","author":"Domsic RT","year":"2011","unstructured":"Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger TA Jr. Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis. 2011, 70:104-9. 10.1136\/ard.2009.127621","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000113","article-title":"Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement","volume":"26","author":"Domsic RT","year":"2014","unstructured":"Domsic RT. Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement. Curr Opin Rheumatol. 2014, 26:646-52. 10.1097\/BOR.0000000000000113","journal-title":"Curr Opin Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/art.39022","article-title":"Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma","volume":"67","author":"Shah AA","year":"2015","unstructured":"Shah AA, Hummers LK, Casciola-Rosen L, Visvanathan K, Rosen A, Wigley FM. Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma. Arthritis Rheumatol. 2015, 67:1053-61. 10.1002\/art.39022","journal-title":"Arthritis Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10426","article-title":"Predictive value of immunological markers in systemic sclerosis","volume":"22","author":"Bobeica C","year":"2021","unstructured":"Bobeica C, Niculet E, Halip AI, et al.. Predictive value of immunological markers in systemic sclerosis. Exp Ther Med. 2021, 22:994. 10.3892\/etm.2021.10426","journal-title":"Exp Ther Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-022-08945-x","article-title":"Renal disease and systemic sclerosis: an update on scleroderma renal crisis","volume":"1","author":"Cole A","year":"2022","unstructured":"Cole A, Ong VH, Denton CP. Renal disease and systemic sclerosis: an update on scleroderma renal crisis. Clin Rev Allergy Immunol. 2022, 1:3-7. 10.1007\/s12016-022-08945-x","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/art.40027","article-title":"Early mortality in a multinational systemic sclerosis inception cohort","volume":"69","author":"Hao Y","year":"2017","unstructured":"Hao Y, Hudson M, Baron M, et al.. Early mortality in a multinational systemic sclerosis inception cohort. Arthritis Rheumatol. 2017, 69:1067-77. 10.1002\/art.40027","journal-title":"Arthritis Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1793960","article-title":"An update on the pharmacotherapeutic options and treatment strategies for systemic sclerosis","volume":"21","author":"McMahan ZH","year":"2020","unstructured":"McMahan ZH, Volkmann ER. An update on the pharmacotherapeutic options and treatment strategies for systemic sclerosis. Expert Opin Pharmacother. 2020, 21:2041-56. 10.1080\/14656566.2020.1793960","journal-title":"Expert Opin Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/128029-progressive-systemic-sclerosis-with-negative-antinuclear-antibodies-and-absence-of-raynauds-phenomenon-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:58Z","timestamp":1707508798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/128029-progressive-systemic-sclerosis-with-negative-antinuclear-antibodies-and-absence-of-raynauds-phenomenon-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.35663","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}